Flow diversion for intracranial aneurysms emerged as an efficacious and durable treatment
option over the last two decades. In a paradigm shift from intrasaccular aneurysm …

Flow diversion with the pipeline embolization device (PED) is increasingly used to treat
intracranial aneurysms with high obliteration rates and low morbidity. However, long-term …

Background The comparative efficacy and safety of first-generation flow diverters (FDs),
Pipeline Embolization Device (PED)(Medtronic, Irvine, California), Silk (Balt Extrusion …

Background and purpose Flow diversion has established as standard treatment for
intracranial aneurysms, the Surpass Streamline is the only FDA-approved braided …

Abstract Purpose Traditional flow diverters (FDs) for treating aneurysms at the fetal posterior
communicating artery are unsatisfactory. Surpass Streamline is a novel FD with different …

Abstract As of January 2021, the Surpass Streamline (SS) is the most recently approved flow
diverter in Japan. A total of 28 Japanese patients, including 9 clinical trial patients, with 28 …

Multiple intracranial aneurysms are difficult to treat. In order to investigate the effect and
safety of endovascular treatment for multiple intracranial aneurysms, 54 consecutive patients …

Background When it comes to intracranial aneurysms, the quest for more effective
treatments is ongoing. Flow diversion represents a growing advancement in this field. This …

Background Flow diverter devices (FDs) are increasingly used for treating unruptured
intracranial aneurysms (UIAs), but limited studies compared different FDs. Objective To …

Background Current evidence comparing flow diverters (FDs) for the treatment of intracranial
aneurysms is limited to single‐arm head‐to‐head retrospective and prospective studies …